Intervention

Oral Placebo

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 11 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials11
Recruiting2
Common conditions22
Lead sponsors shown10
Advertisement

Clinical trials

11 shown
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive DisorderNCT07227454 · 2026-01-08
RECRUITING
Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized PatientsNCT05558007 · 2023-11-22
RECRUITING
Enhancing the Natriuretic Peptide System in HFpEFNCT05279742 · 2022-11-04
ENROLLING_BY_INVITATION
Rapid Antidepressant Improvement Secondary to Excitatory Brain ResponsesNCT04276259 · 2020-10-19
COMPLETED
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)NCT04246177 · 2020-05-22
TERMINATED
Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer PatientsNCT03469271 · 2018-05-25
COMPLETED
Study to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS) ( ULTIMATE 1 )NCT03277261 · 2017-09-19
COMPLETED
Study to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS)NCT03277248 · 2017-08-25
COMPLETED
Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial HypertensionNCT02682511 · 2017-01-01
ACTIVE_NOT_RECRUITING
Primary Intervention With Mucosal InsulinNCT02620553 · 2007-09-01
COMPLETED
Cannabis for Spasticity in Multiple SclerosisNCT00682929 · 2004-04-14
TERMINATED

Common conditions

Trial status mix

COMPLETED5
RECRUITING2
TERMINATED2
ACTIVE_NOT_RECRUITING1
ENROLLING_BY_INVITATION1

Phase mix

PHASE25
PHASE34
PHASE13
PHASE42
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.